Effect of intravenous and intracoronary melatonin as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: Results of the Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty trial

Journal of Pineal Research

Volumn 62, Issue 1, 2017, Pages

  Dominguez Rodriguez, Alberto ^a,b   Abreu Gonzalez, Pedro ^c   de la Torre Hernandez, Jose M ^d   Gonzalez Gonzalez, Julia ^a   Garcia Camarero, Tamara ^d   Consuegra Sanchez, Luciano ^e   Garcia Saiz, Maria del Mar ^a   Aldea Perona, Ana ^a   Virgos Aller, Tirso ^a   Azpeitia, Agueda ^f   Reiter, Russel J ^g   Caballero Estevez, Natalia ^h   de la Rosa, Alejandro ^h   Nazco Casariego, Julia ^h   Poderós, Teresa Giménez ^h   Laynez Cerdeña, Ignacio ^h   Bosa Ojeda, Francisco ^h   Sanchez Grande, Alejandro ^h   Yanes Bowden, Geoffrey ^h   Vargas Torres, Manuel ^h   Lara Padrón, Antonio ^h   Perez Jorge, Pablo ^h   Diaz Flores, Lucio ^h   Lopez, Jorge ^h   Lacalzada Almeida, Juan ^h   Duque, Amelia ^h   Bethencourt, Miguel ^h   Izquierdo, Mariela ^h   Juarez Prera, Ruben ^h   Blanco Palacios, Gabriela ^h   Barragan Acea, Antonio ^h   Ferrer Hita, Julio ^h   Marí Lopez, Belen ^h   Padilla, Marta ^h   Gonzalez, Esther ^h   Martin Cabeza, Marta ^h   Mendez Vargas, Corabel ^h   Barrios, Patricia ^h   Belleyo Belkasem, Carima ^h   Leiva, Miguel ^h   Betancor, Ivan ^h   Miranda, Julio ^h   Soria Arcos, Federico ^h   Martinez, Lourdes ^h   more..

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b Facultad de Ciencias de la Salud   (Spain)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^f Onmedic Networks   (Spain)

^g Mays Cancer Center at UT Health San Antonio   (United States)

^h NONE

Author keywords

acute myocardial infarction; heart ischaemia reperfusion injury; infarct size; melatonin; mitochondria; primary angioplasty

Indexed keywords

MELATONIN;

ACUTE HEART INFARCTION; ADD ON THERAPY; ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; REPERFUSION INJURY; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL REPERFUSION INJURY; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; ST ELEVATION MYOCARDIAL INFARCTION;

ANGIOPLASTY, BALLOON, CORONARY; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; ST ELEVATION MYOCARDIAL INFARCTION;

EID: 84996587667     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12374     Document Type: Article

References (33)

1. Ong SB, Samangouei P, Kalkhoran SB, et al. The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury. J Mol Cell Cardiol. 2015;78:23–34.
2. Yang Y, Sun Y, Yi W, et al. A review of melatonin as a suitable antioxidant against myocardial ischemia-reperfusion injury and clinical heart diseases. J Pineal Res. 2014;57:357–366.
3. Reiter RJ, Tan DX, Paredes SD, et al. Beneficial effect of melatonin in cardiovascular disease. Ann Med. 2010;42:276–285.
4. Petrosillo G, Di Venosa N, Pistolese M, et al. Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemia- reperfusion: role of cardiolipin. FASEB J. 2006;20:269–276.
5. Petrosillo G, Colantuono G, Moro N, et al. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Physiol Heart Circ Physiol. 2009;297:H1487–H1493.
6. Petrosillo G, Moro N, Paradies V, et al. Increased susceptibility to Ca(2+)-induced permeability transition and to cytochrome C release in rat heart mitochondria with aging: effect of melatonin. J Pineal Res. 2010;48:340–346.
7. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, et al. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of melatonin as an adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale. Contemp Clin Trials. 2007;28:532–539.
8. Grossini E, Molinari C, Uberti F, et al. Intracoronary melatonin increases coronary blood flow and cardiac function through β-adrenoreceptors, MT1/MT2 receptors, and nitric oxide in anesthetized pigs. J Pineal Res. 2011;51:246–257.
9. Silber S, Albertsson P, Avilés FF, et al. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J. 2005;26:804–847.
10. Kramer CM, Barkhausen J, Flamm SD, et al. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson. 2013;15:91.
11. Mahaffey KW, Puma JA, Barbagelata NA, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol. 1999;34:1711–1720.
12. Bøtker HE, Kharbanda R, Schmidt MR, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010;375:727–734.
13. Siddiqi N, Neil C, Bruce M, et al. Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI). Eur Heart J. 2014;35:1255–1262.
14. Bulluck H, Yellon DM, Hausenloy DJ. Reducing myocardial infarct size: challenges and future opportunities. Heart. 2016;102:341–348.
15. Fröhlich GM, Meier P, White SK, et al. Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J. 2013;34:1714–1722.
16. Atar D, Arheden H, Berdeaux A, et al. Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results. Eur Heart J. 2015;36:112–119.
17. Gibson CM, Giugliano RP, Kloner RA, et al. EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention. Eur Heart J. 2016;37:1296–1303.
18. Piot C, Croisille P, Staat P, et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med. 2008;359:473–481.
19. Mewton N, Croisille P, Gahide G, et al. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol. 2010;55:1200–1205.
20. Cung TT, Morel O, Cayla G, et al. Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med. 2015;373:1021–1031.
21. Paradise G, Petrosillo G, Paradise V, et al. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res. 2010;48:297–310.
22. Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, et al. Melatonin and circadian biology in human cardiovascular disease. J Pineal Res. 2010;49:14–22.
23. Manchester LC, Coto-Montes A, Boga JA, et al. Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res. 2015;59:403–419.
24. Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P. The role of melatonin in acute myocardial infarction. Front Biosci. 2012;17:2433–2441.
25. Tengattini S, Reiter RJ, Tan DX, et al. Cardiovascular diseases: protective effects of melatonin. J Pineal Res. 2008;44:16–25.
26. Andersen LP, Gögenur I, Rosenberg J, et al. The safety of melatonin in humans. Clin Drug Investig. 2016;36:169–175.
27. Gögenur I, Kücükakin B, Panduro Jensen L, et al. Melatonin reduces cardiac morbidity and markers of myocardial ischemia after elective abdominal aortic aneurism repair: a randomized, placebo-controlled, clinical trial. J Pineal Res. 2014;57:10–15.
28. Dwaich KH, Al-Amran FG, Al-Sheibani BI, et al. Melatonin effects on myocardial ischemia-reperfusion injury: impact on the outcome in patients undergoing coronary artery bypass grafting surgery. Int J Cardiol. 2016;221:977–986.
29. Denktas AE, Anderson HV, McCarthy J, et al. Total ischemic time: the correct focus of attention for optimal ST-segment elevation myocardial infarction care. JACC Cardiovasc Interv. 2011;4:599–604.
30. Koenig GC, Rowe RG, Day SM, et al. MT1-MMP-dependent remodeling of cardiac extracellular matrix structure and function following myocardial infarction. Am J Pathol. 2012;180:1863–1878.
31. Drobnik J, Tosik D, Piera L, et al. Melatonin-induced glycosaminoglycans augmentation in myocardium remote to infarction. J Physiol Pharmacol. 2013;64:737–744.
32. Drobnik J, Owczarek K, Piera L, et al. Melatonin-induced augmentation of collagen deposition in culture of fibroblasts and myofibroblasts is blocked by luzindole – a melatonin membrane receptor inhibitor. Pharmacol Rep. 2013;65:642–649.
33. Hausenloy DJ, Botker HE, Engstrom T, et al. Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. Eur Heart J. 2016. doi: 10.1093/eurheartj/ehw145.